JP2011037901A5 - - Google Patents

Download PDF

Info

Publication number
JP2011037901A5
JP2011037901A5 JP2010261857A JP2010261857A JP2011037901A5 JP 2011037901 A5 JP2011037901 A5 JP 2011037901A5 JP 2010261857 A JP2010261857 A JP 2010261857A JP 2010261857 A JP2010261857 A JP 2010261857A JP 2011037901 A5 JP2011037901 A5 JP 2011037901A5
Authority
JP
Japan
Prior art keywords
compound
hydrochloride
tandospirone
buspirone
amd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010261857A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011037901A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011037901A publication Critical patent/JP2011037901A/ja
Publication of JP2011037901A5 publication Critical patent/JP2011037901A5/ja
Withdrawn legal-status Critical Current

Links

JP2010261857A 2000-03-17 2010-11-24 網膜外縁部障害の処置に有用な5−ht1a活性を有する化合物 Withdrawn JP2011037901A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19027900P 2000-03-17 2000-03-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001568420A Division JP4789231B2 (ja) 2000-03-17 2001-02-23 網膜外縁部障害の処置に有用な5−ht1a活性を有する化合物

Publications (2)

Publication Number Publication Date
JP2011037901A JP2011037901A (ja) 2011-02-24
JP2011037901A5 true JP2011037901A5 (US20080131398A1-20080605-C00009.png) 2012-01-05

Family

ID=22700682

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2001568421A Pending JP2003527423A (ja) 2000-03-17 2001-02-20 緑内障処置用の5−ht2および5−ht1aアゴニスト活性を有する化合物
JP2001568420A Expired - Fee Related JP4789231B2 (ja) 2000-03-17 2001-02-23 網膜外縁部障害の処置に有用な5−ht1a活性を有する化合物
JP2001568428A Withdrawn JP2003527427A (ja) 2000-03-17 2001-02-23 視野損失を抑制するのに有用な5−ht活性を有する化合物
JP2010261857A Withdrawn JP2011037901A (ja) 2000-03-17 2010-11-24 網膜外縁部障害の処置に有用な5−ht1a活性を有する化合物
JP2011108785A Withdrawn JP2011153158A (ja) 2000-03-17 2011-05-13 網膜外縁部障害の処置に有用な5−ht1a活性を有する化合物

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2001568421A Pending JP2003527423A (ja) 2000-03-17 2001-02-20 緑内障処置用の5−ht2および5−ht1aアゴニスト活性を有する化合物
JP2001568420A Expired - Fee Related JP4789231B2 (ja) 2000-03-17 2001-02-23 網膜外縁部障害の処置に有用な5−ht1a活性を有する化合物
JP2001568428A Withdrawn JP2003527427A (ja) 2000-03-17 2001-02-23 視野損失を抑制するのに有用な5−ht活性を有する化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011108785A Withdrawn JP2011153158A (ja) 2000-03-17 2011-05-13 網膜外縁部障害の処置に有用な5−ht1a活性を有する化合物

Country Status (19)

Country Link
EP (3) EP1263434A1 (US20080131398A1-20080605-C00009.png)
JP (5) JP2003527423A (US20080131398A1-20080605-C00009.png)
KR (3) KR20030016239A (US20080131398A1-20080605-C00009.png)
CN (2) CN1198605C (US20080131398A1-20080605-C00009.png)
AR (1) AR028258A1 (US20080131398A1-20080605-C00009.png)
AT (1) ATE247507T1 (US20080131398A1-20080605-C00009.png)
AU (5) AU2001238552A1 (US20080131398A1-20080605-C00009.png)
BR (3) BR0109193A (US20080131398A1-20080605-C00009.png)
CA (3) CA2400637A1 (US20080131398A1-20080605-C00009.png)
DE (1) DE60100625T2 (US20080131398A1-20080605-C00009.png)
DK (1) DK1263504T3 (US20080131398A1-20080605-C00009.png)
ES (1) ES2204848T3 (US20080131398A1-20080605-C00009.png)
HK (1) HK1051504A1 (US20080131398A1-20080605-C00009.png)
MX (3) MXPA02009071A (US20080131398A1-20080605-C00009.png)
PL (1) PL203709B1 (US20080131398A1-20080605-C00009.png)
PT (1) PT1263504E (US20080131398A1-20080605-C00009.png)
TW (1) TWI268777B (US20080131398A1-20080605-C00009.png)
WO (3) WO2001070223A1 (US20080131398A1-20080605-C00009.png)
ZA (1) ZA200206350B (US20080131398A1-20080605-C00009.png)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
BR0109193A (pt) * 2000-03-17 2003-05-27 Alcon Inc Compostos com atividade agonista 5-ht2 e 5-ht1a para tratamento do glaucoma
US20030207890A1 (en) 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
AU2003300915B2 (en) 2002-12-13 2008-08-28 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
JP2004262812A (ja) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd 眼圧低下剤
CN100563648C (zh) * 2003-04-25 2009-12-02 田边三菱制药株式会社 包含亚烷基二氧苯衍生物的口服组合物
US7476687B2 (en) 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US6989445B2 (en) 2003-12-15 2006-01-24 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
WO2006022420A1 (ja) 2004-08-25 2006-03-02 Takeda Pharmaceutical Company Limited 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
WO2006062839A1 (en) 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
WO2007132841A1 (ja) 2006-05-16 2007-11-22 Takeda Pharmaceutical Company Limited 縮合複素環化合物およびその用途
WO2008024846A2 (en) * 2006-08-25 2008-02-28 Allergan, Inc. Brimonidine and timolol compositions
EP2896624B1 (en) 2007-03-28 2016-07-13 Atir Holding S.A. Heterotricyclic compounds as serotonergic and/or dopaminergic agents and uses thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
US20110124736A1 (en) 2009-11-09 2011-05-26 Allergan, Inc. Compositions and methods for stimulating hair growth
JPWO2011071136A1 (ja) 2009-12-11 2013-04-22 アステラス製薬株式会社 線維筋痛症治療剤
WO2014127243A1 (en) 2013-02-15 2014-08-21 Allergan, Inc. Sustained drug delivery implant
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬
AU2020228289A1 (en) 2019-02-27 2021-09-09 The Regents Of The University Of California N-substituted indoles and other heterocycles for treating brain disorders
CN113784962A (zh) 2019-02-27 2021-12-10 加利福尼亚大学董事会 用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环
WO2023118544A1 (en) * 2021-12-23 2023-06-29 Cilcare Dev 4-phenyl-tetrahydropyridine derivatives for treating hearing diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02262518A (ja) * 1989-04-03 1990-10-25 Kaken Pharmaceut Co Ltd 眼圧調整剤
JP2824863B2 (ja) * 1989-07-12 1998-11-18 エーザイ株式会社 α▲下1▼―ブロッカー点眼剤
TW270114B (US20080131398A1-20080605-C00009.png) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5521183A (en) * 1994-08-30 1996-05-28 Allergan Use of 5-HT ligands as anti-pruritic agents
US5998467A (en) * 1995-10-25 1999-12-07 Mitsubishi Chemical Corporation Medicine for oculopathy
JP3958391B2 (ja) * 1995-10-25 2007-08-15 三菱化学株式会社 眼疾患用薬剤
WO1998018458A1 (en) * 1996-10-31 1998-05-07 Alcon Laboratories, Inc. Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
GB9819033D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds VI
BR0109193A (pt) * 2000-03-17 2003-05-27 Alcon Inc Compostos com atividade agonista 5-ht2 e 5-ht1a para tratamento do glaucoma

Similar Documents

Publication Publication Date Title
JP2011037901A5 (US20080131398A1-20080605-C00009.png)
EA201700230A1 (ru) Определенные аминопиридины, композиции на их основе и способы их применения
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
JP2013514381A5 (US20080131398A1-20080605-C00009.png)
JP2012502885A5 (US20080131398A1-20080605-C00009.png)
EA201891861A1 (ru) 2-(морфолин-4-ил)-1,7-нафтиридины
AR078766A1 (es) Formas solidas de n-(4-(7-azabiciclo(2.2.1) heptan-7-il)-2-( trifluorometil) fenil)-4-oxo-5-(trifluorometil)-1,4- dihidroquinolina-3-carboxamida
CY1116791T1 (el) 4-αρυλ-ν-φαινυλ-1,3,5-τριαζιν-αμινες που περιεχουν μια ομαδα σουλφοξιμινης
EA201500953A1 (ru) 3-ацетиламино-1-(фенилгетероариламинокарбонил или фенилгетероарилкарбониламино)бензольные производные для лечения гиперпролиферативных нарушений
JP2011518833A5 (US20080131398A1-20080605-C00009.png)
JP2016501250A5 (US20080131398A1-20080605-C00009.png)
JP2012092103A5 (US20080131398A1-20080605-C00009.png)
WO2012016186A8 (en) Macrocyclic kinase inhibitors and uses thereof
JP2013508347A5 (US20080131398A1-20080605-C00009.png)
WO2014209841A3 (en) Compounds for treating spinal muscular atrophy
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
PE20120989A1 (es) Sales de disacarina, acido difumarico, acido d-1-hidroxi-2-naftoico y monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino) pirimidin-5-il) metil) fenil) acetato de 4-(dimetilamino) butilo
NZ600801A (en) Substituted imidazopyridinyl-aminopyridine compounds
EA201201377A1 (ru) Определенные аминопиридазины, композиции на их основе и способы их использования
NZ603800A (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
JP2014513036A5 (US20080131398A1-20080605-C00009.png)
EA201400311A1 (ru) Аминозамещенные имидазопиридазины
MX343620B (es) Forma polimorfica de clorhidrato de pridopidina.
JP2009538861A5 (US20080131398A1-20080605-C00009.png)